NOVARTIS PHARMACEUTICALS UK LIMITED: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·Main market: Pharmaceutical products
Official UK PPONPJTX-5182-QVLRCompanies House00119006 ↗ · Active
Where they wini
i
84 awards (82 for a named lot, 98%, 2 for a whole procedure with no lot named) · top CPV classes, shares of all 84 awards. An award may cover more than one class.
3360 Pharmaceutical products70 awards · 83% · 68 awards naming a lot + 2 whole-procedure awards3369 Various medicinal products2 awards · 2% · awards naming a loti
i
Largest published awards i | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Proprietary Drugs | eTenderwales | — | — | £8,735,000 † |
| Proprietary Drugs | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £6,929,923 † |
| WT2025-07 - SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection | Western Health and Social Care Trust | 10 Nov 2025 | 3 yrs | £4,638,166 ≈ £1.5m/yr |
| ZOLGENSMA 2 X 10 EXP 13 VECTOR GENOMES/ML Solution for Infusion 1 Treatment Pack Pack | Belfast Health and Social Care Trust | — | — | £2,692,500 † |
| PRRT (Peptide Receptor Radionuclide Therapy) | Belfast Health and Social Care Trust | 10 Nov 2025 | 1.1 yrs | £1,820,000 ≈ £1.7m/yr |
Where their buyers arei
i
ITL1 region of the buyer office · known for 77 of 77 awarded procedures · each procedure counts once
Bidding recordi
i
Procurement Act 2023 award notices name every bidder · 9 notices name this supplier, covering 11 lots since 20 Aug 2025 · observed bids, not an estimate
i
i
i
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointedall 2 lots bid for | 125 | 9 Oct 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | NHS England | not appointed | 41 | 6 Jul 2026 |
| NHS National Branded Interim - 1 June 2026 | NHS England | appointed | 53 | 22 May 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | not appointed | 118 | 26 Feb 2026 |
| NHS National Framework Agreement for Omalizumab | NHS England | appointed | 3 | 30 Dec 2025 |
| NHS National Framework for Generics Housekeeping | NHS England | appointed | 53 | 22 Dec 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England | appointed | 17 | 6 Oct 2025 |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) | NHS England | appointed | 15 | 4 Sept 2025 |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | NHS England | appointed | 17 | 20 Aug 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health96%(81 awards)
81 of 84 awards are NHS & health (96%).Type not classified4%(3 awards)
3 of 84 awards are Type not classified (4%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 27 | 35.1% | 37 | 27 Aug 2026 |
| Belfast Health and Social Care Trust | 18 | 23.4% | 18 | 8 Sept 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 9 | 11.7% | 13 | 25 Jul 2025 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 5 | 6.5% | 5 | 17 Sept 2026 |
| Northern Health and Social Care Trust | 5 | 6.5% | 5 | 13 Aug 2025 |
| The NHS Commissioning Board (operating under the name of NHS England) | 3 | 3.9% | 5 | 10 Feb 2021 |
| Cambridge University Hospitals NHS Foundation Trust | 3 | 3.9% | 3 | 19 Jun 2026 |
| Western Health and Social Care Trust | 2 | 2.6% | 2 | 10 Nov 2025 |
Share = of the 77 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
61 of 94 awards carry an end date, 10 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| PRRT (Peptide Receptor Radionuclide Therapy) | 31 Dec 2026 | £1,820,000 |
| Generic Drugs - Tablets & Capsules | 31 Jan 2027 | £926,282 |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | 31 Jan 2027 | £1 ceiling |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | 31 Jan 2027 | £22,097,000 ceiling |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) | 31 Jan 2027 | £52,385,000 ceiling |
| Transitional Drugs 4 | 31 Jan 2027 | £137,717 ceiling |
| Lot 1 - CM/PHS/25/5728/01 | 31 May 2027 | £688,834,174 ceiling |
| Lot 1 - CM/TNS/25/5734 | 31 Aug 2027 | £87,433,000 ceiling |
| NHS National Framework for Generics Housekeeping - Lot 2 Hospital Only products | 30 Sept 2027 | £21,562,716 ceiling |
| TRAMETINIB 2MG TABLETS, 30 tablet, pack | 31 Mar 2028 | £270,000 |
Soonest 10 of 12.
Recent awards
Latest 30 of 85 award records naming this supplier
Contracts Finder adds 9 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 51 of 94 awards, estimated from the published duration on 10 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.